<DOC>
	<DOCNO>NCT00989313</DOCNO>
	<brief_summary>This study design follow patient , participate PEP005-028 study observe complete clearance Actinic Keratosis ( AK ) lesion , 12 month period ass recurrence AK lesion long term safety select treatment area .</brief_summary>
	<brief_title>A Long Term Follow Study Patients Who Have Complete Clearance Their Actinic Keratosis ( AK ) Lesions Day 57 Visit PEP005-028 Study</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Inclusion Patient provide informed consent document signing Informed Consent Form ( ICF ) prior studyrelated procedure Patient achieve complete clearance AK lesion ( lesion count 0 ) select treatment area Day 57 visit follow Peplin AK clinical Study : PEP005028 Exclusion Concurrent participation another research study would involve select treatment area ( except poststudy followup visit previous Peplin AK study ) Early termination study PEP005028</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Peplin</keyword>
	<keyword>Actinic keratosis</keyword>
	<keyword>PEP005</keyword>
</DOC>